Oral PCSK9 Inhibitor Enlicitide Versus Oral Nonstatin Therapies

Alberico L. Catapano, Elina Mikhailova, Ann Marie Navar, Puja Banka, Pablo Corral, Manish Saxena, P.Gabriel Steg, Subodh Verma, Andrew Yacoub Kordahi, Geraldine Mendizabal, Pengfei Zhu, Christie M. Ballantyne, Chau-Chung Wu, Chii-Min Hwu, Kai-Chien Yang, Ping-Yen Liu, Kuo-Chun Hung, Sybil Charriere, Bertrand Cariou, Gabriel Steg, Francois Roubille, Oren Caspi, Gil Moravsky, Victor Vishlitzky, Amos Katz, Carlos Brotons Cuixart, Francisco Jose Tinahones Madueno, Nuria Rial Lorenzo, Maria Urquizu-Padilla, Alex Vila Belmonte, Alfonso Soto Gonzalez, Devaki R. Nair, Manish Saxena, Umasuthan Srirangalingam, Cesar Javier Zaidman, Ezequiel Hector Vottero, Pablo Corral, Harold E. Bays, Frances Eileen Broyles, Sheryl M. Marks, Shishir Kumar Khetan, Paul Gerard Matherne, Amit G. Shah, Ronald Stumbris, Jeffrey D. Wayne, Jean-francois Naud, A. Shekhar Pandey, Jean-Claude Tardif, Subodh Verma, John Vyselaar, Christie M. Ballantyne